Compare · BTSG vs TOI
BTSG vs TOI
Side-by-side comparison of BrightSpring Health Services Inc. (BTSG) and The Oncology Institute Inc. (TOI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BTSG and TOI operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- BTSG is the larger of the two at $11.32B, about 22.1x TOI ($512.9M).
- Over the past year, BTSG is up 152.2% and TOI is up 46.7% - BTSG leads by 105.5 points.
- TOI has been more active in the news (7 items in the past 4 weeks vs 1 for BTSG).
- BTSG has more recent analyst coverage (23 ratings vs 8 for TOI).
- Company
- BrightSpring Health Services Inc.
- The Oncology Institute Inc.
- Price
- $60.40+5.48%
- $5.12+5.13%
- Market cap
- $11.32B
- $512.9M
- 1M return
- -16.67%
- -3.12%
- 1Y return
- +152.22%
- +46.70%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2024
- 2020
- News (4w)
- 1
- 7
- Recent ratings
- 23
- 8
The Oncology Institute Inc.
The Oncology Institute, Inc. provides cancer awareness, prevention, diagnosis, treatment, and education service. The company offers chemotherapy education, comprehensive lab testing, pain management, financial counseling, end of life counseling, dietary counseling, in-house infusion center, in-house support groups, in-house pharmacy, nutraceuticals, clinical trials, and educational seminars. It also operates the hope, health, and healing center to offer patients alternative and holistic treatments in addition to chemotherapy. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Latest BTSG
- Amendment: SEC Form SCHEDULE 13G/A filed by BrightSpring Health Services Inc.
- SEC Form 10-Q filed by BrightSpring Health Services Inc.
- BrightSpring Health Services Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
- Officer Rousseau Jon B covered exercise/tax liability with 56,319 shares, decreasing direct ownership by 5% to 1,138,184 units (SEC Form 4) to cover withholding tax
- BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600
- Guggenheim initiated coverage on BrightSpring Health Services with a new price target
- Raymond James initiated coverage on BrightSpring Health Services with a new price target
- BrightSpring Health Services, Inc. to Announce Second Quarter 2026 Financial Results on July 31, 2026
- President, PharMerica Greenwell Scott A. covered exercise/tax liability with 2,487 shares, decreasing direct ownership by 7% to 34,372 units (SEC Form 4) to satisfy withholding obligation
Latest TOI
- Director Hively Brad sold $1,946,310 worth of shares (298,853 units at $6.51), decreasing direct ownership by 42% to 411,976 units (SEC Form 4)
- The Oncology Institute Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Large owner Chernett Jorey bought $78,480 worth of shares (12,000 units at $6.54), increasing direct ownership by 0.11% to 10,660,858 units (SEC Form 4)
- SEC Form 10-Q filed by The Oncology Institute Inc.
- The Oncology Institute Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Oncology Institute Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- The Oncology Institute Rebrands as Starling Oncology
- Director Kaushal Mohit was granted 33,133 shares, increasing direct ownership by 19% to 205,716 units (SEC Form 4)
- Director Mcgeorge Anne was granted 41,165 shares, increasing direct ownership by 14% to 332,535 units (SEC Form 4)
- Director Pacala Mark L was granted 30,120 shares, increasing direct ownership by 12% to 286,881 units (SEC Form 4)